TOP 100 BIOTECHNOLOGY SPEAKERS FOR EVENTS: HEALTHCARE FUTURIST KEYNOTE EXPERTS FOR HIRE

Today’s Top 100 biotechnology speakers for events who keynote note that the it has become a driving force in the healthcare sector, offering innovative solutions to some of the world’s most pressing challenges. Leading executives, researchers, and influencers from the healthcare, pharmaceutical, and health insurance space on the Top 100 biotechnology speakers list are at the vanguard of this revolution.

For example, consider futurist keynote and consulting expert for 3000 brands Scott Steinberg. As a Top 100 biotechnology speakers standout, he’s worked with countless healthcare companies and associations to explore the topic and what it means for the future of medicine and medical systems.

From groundbreaking drug therapies to advancements in personalized medicine though, loads of thought leaders are helping redefine the future of healthcare. We consider Top 100 biotechnology speakers who are leading the way.

And PS, also keep in mind if you’re planning a corporate meeting, conference or convention event that you may have your own favorites as well. You can always submit Top 100 biotechnology speakers candidates who you feel make the cut too.

1. Scott Steinberg – Founder of FutureProof Strategies, leading consultant on biotech innovations in health and technology.

2. Albert Bourla – CEO of Pfizer, leading the company’s vaccine and biotechnology research.

3. Emma Walmsley – CEO of GlaxoSmithKline, advancing the pharmaceutical and biotechnology sectors.

4. Vasant Narasimhan – CEO of Novartis, leading the charge in gene therapy and biotech solutions.

5. Severin Schwan – CEO of Roche, advancing biotechnology in diagnostics and personalized medicine.

6. Pascal Soriot – CEO of AstraZeneca, spearheading innovations in oncology and immunology.

7. David Ricks – CEO of Eli Lilly, pioneering advancements in diabetes, oncology, and biotech.

8. George Scangos – CEO of Vir Biotechnology, advancing viral therapeutics and vaccines.

9. Lars Fruergaard Jørgensen – CEO of Novo Nordisk, leading biotechnology innovations in diabetes and obesity treatments.

10. Stéphane Bancel – CEO of Moderna, revolutionizing vaccine technology with mRNA platforms.

11. John Milligan – Former CEO of Gilead Sciences, innovating in HIV and liver disease treatments.

12. Jim Greenwood – CEO of BIO, the Biotechnology Innovation Organization, shaping policy and biotech advocacy.

13. Frans van Houten – CEO of Philips Healthcare, leading medical technology innovations in biotechnology.

14. Bill Gates – Co-founder of Bill & Melinda Gates Foundation, investing in biotech for global health initiatives.

15. Jean-Michel Halfon – CEO of Ipsen, advancing the company’s biotechnology efforts in oncology and rare diseases.

16. Richard Pops – CEO of Alkermes, innovating in mental health and oncology treatments.

17. Mark Alles – Former CEO of Celgene, advancing cancer and inflammatory disease treatments.

18. Robert Bradway – CEO of Amgen, leading innovations in biologic drugs for cancer and cardiovascular diseases.

19. Mike Wirth – CEO of Chevron, focusing on the intersection of biotechnology and energy solutions for healthcare.

20. Sharon Shacham – Co-founder of Karyopharm Therapeutics, pioneering work in targeted therapies for cancer.

21. John Maraganore – CEO of Alnylam Pharmaceuticals, leading RNA interference technology to treat genetic diseases.

22. Lisa Su – CEO of Advanced Micro Devices (AMD), exploring the use of semiconductor technology in biotechnology applications.

23. Michael Pearson – Former CEO of Valeant Pharmaceuticals, advancing biotech strategies in pharmaceuticals.

24. Dylan Taylor – Chairman of Voyager Therapeutics, pioneering innovations in gene therapy.

25. Lynn Seely – CEO of Myovant Sciences, advancing women’s health and oncology biotech solutions.

26. Charles Homcy – Partner at Third Rock Ventures, funding biotechnology companies in gene therapy and cancer research.

27. Marc Tessier-Lavigne – President of Stanford University, contributing to biotechnology research in neuroscience.

28. Christopher Viehbacher – CEO of Sanofi, shaping the future of immuno-oncology and vaccines.

29. Peter J. Wirth – CEO of MassBio, leading the Massachusetts Biotechnology Council.

30. David Loew – CEO of Ipsen, focusing on oncology, rare diseases, and biotechnology-driven medical solutions.

31. Kathy High – CEO of Athersys, advancing regenerative medicine and stem cell therapies.

32. Robert Langer – Co-founder of Moderna, a pioneer in biotechnology and pharmaceutical development.

33. Jonas Salk – Virologist and medical researcher, influencing biotechnology through vaccine research and innovation.

34. Catherine J. Tuggle – CEO of Immune Design, innovating immuno-oncology therapies.

35. Daniel O’Day – CEO of Gilead Sciences, leading research in liver diseases and HIV/AIDS.

36. Samantha Du – Founder and CEO of Zai Lab, focusing on biopharmaceutical and biotechnology innovations in China.

37. Chris Gibson – CEO of Recursion Pharmaceuticals, using AI to revolutionize drug discovery.

38. Sandeep Gupta – Senior Vice President of Biogen, leading the development of treatments for neurological diseases.

39. Celine Gounder – Physician and public health expert, advising on biotechnology solutions in infectious disease.

40. Raymond C. Schinazi – Co-founder of Pharmasset, pioneering research in antiviral drugs for hepatitis C.

41. Francis Collins – Director of the National Institutes of Health (NIH), driving federal support for biotechnology and medical research.

42. A. Lawrence Korman – CEO of Ferring Pharmaceuticals, leading innovations in biotechnology for fertility and endocrinology.

43. Ruth Shuman – Chief Science Officer at Intellia Therapeutics, advancing CRISPR technology in gene editing.

44. Patrick Soon-Shiong – Founder of NantWorks, a leading figure in biotech oncology and personalized medicine.

45. Vicky Fox – CEO of Adverum Biotechnologies, advancing ocular gene therapy.

46. Bruce Darrow – Senior Vice President of Mount Sinai Health System, integrating biotechnology into healthcare systems.

47. Janet Woodcock – Former Director of FDA Center for Drug Evaluation, influencing biotechnology regulations.

48. John S. M. Pease – President of Alcon, focusing on biotechnological advances in eye care.

49. Andreas Cangellaris – CEO of Versant Ventures, funding biotech firms in oncology and rare diseases.

50. Jeffrey Leiden – CEO of Vertex Pharmaceuticals, leading innovation in cystic fibrosis treatments.

51. Kenneth Frazier – CEO of Merck & Co., advancing oncology, vaccine, and immune therapies.

52. Dr. Julie Gerberding – Former Director of CDC, a leader in global health and infectious disease biotech solutions.

53. Mikael Dolsten – Chief Scientific Officer at Pfizer, contributing to vaccine development and medical research.

54. Gerry McMahon – Chief Scientific Officer at Exelixis, leading oncology-based biotech initiatives.

55. Geraldine Hamilton – CEO of Emulate, innovating with organ-on-a-chip technology for drug development.

56. Francine Kaufman – Chief Medical Officer at Medtronic, focusing on diabetes and medical device biotechnology.

57. Vijay Tiwari – CEO of Freenome, focusing on early cancer detection using biotechnology.

58. Evan Snyder – Director of Stem Cell Program at Sanford Burnham Prebys, leading regenerative medicine efforts.

59. Julia Greenstein – Senior Vice President at Alnylam Pharmaceuticals, pioneering rare disease treatments.

60. Thomas Cueni – Director of International Federation of Pharmaceutical Manufacturers & Associations, advocating for global biotech policies.

61. Rafael Rabadan – Co-director of Cancer Genomics at Columbia University, pioneering biotech in oncology research.

62. Marc Johnson – Chief Strategy Officer at Medtronic, steering the company’s biotechnology innovations.

63. Andreas Bergmann – CEO of Medivation, advancing biotech therapies for cancer treatment.

64. Laura Shawver – CEO of Silk Road Medical, advancing biotechnology in medical devices and vascular health.

65. Steve Burrill – Founder of Burrill & Company, investing in biotechnology-driven healthcare initiatives.

66. David McGivern – CEO of Merck Sharp & Dohme, contributing to vaccine and immunology research.

67. Tom Hyde – Senior VP of Regeneron Pharmaceuticals, pushing forward breakthroughs in biotechnology and genetics.

68. David H. Austin – CEO of Vir Biotechnology, focusing on novel antiviral therapies.

69. Anil Soni – CEO of Global Infectious Diseases Foundation, advancing global biotechnology solutions in infectious diseases.

70. Martin Bobak – Chief Innovation Officer at Roche, pushing the envelope on biotechnology in molecular diagnostics.

71. Jeff Zients – Former Director of COVID-19 Task Force, driving pandemic response using biotechnology.

72. Olivier Brandicourt – CEO of Sanofi, advancing immunotherapies and vaccines.

73. Maria T. Zuber – Vice President for Research at MIT, advancing biotech and space technologies.

74. John L. Thiel – CEO of Eli Lilly, focusing on biotechnology for autoimmune diseases.

75. George Yancopoulos – President of Regeneron Pharmaceuticals, advancing genetic research and biotech solutions.

76. Adrian Rawcliffe – CEO of Adaptimmune, pushing immuno-oncology biotechnology forward.

77. Bruce Beutler – Director at The Center for the Genetics of Host Defense, pioneering work in immune response biotech.

78. Anna E. Wintour – CEO of Vogue, advocating for biotech solutions in fashion technology.

79. Stephan T. Gijbels – Executive Director of CellaVision, innovating with biotech in diagnostic imaging.

80. Michael J. Fox – Founder of Michael J. Fox Foundation, leading efforts to find a cure for Parkinson’s Disease through biotechnology.

81. James Trager – CEO of GSK Vaccines, advancing vaccine development with biotechnology.

82. Elliot Grant – CEO of PaxVax, pioneering biotech solutions for travel vaccines.

83. Andrew Lo – Professor at MIT, contributing to biotech innovation in drug discovery.

84. Michael F. Stankiewicz – CEO of BioMarin Pharmaceuticals, advancing gene therapies for rare diseases.

85. Steven Rosenberg – Chief of Surgery at National Cancer Institute, a pioneer in gene therapy and cancer vaccines.

86. Barbara L. Atkinson – President of Atkinson Medical, focusing on biotechnological breakthroughs in cancer.

87. Kenneth P. Newman – CEO of ViroPharma, leading the way in viral disease biotechnology.

88. Gail M. O’Connor – Senior Vice President at Merck, driving innovative vaccine biotechnology initiatives.

89. Paul von Hippel – Chief Innovation Officer at Bristol-Myers Squibb, leading the future of biotechnology in oncology.

90. Shiladitya Sengupta – Founder of Sengupta Biotech, focusing on nanotechnology in drug delivery systems.

91. Nancy D. Witty – CEO of Bio-Techne, providing leadership in diagnostics and life sciences biotechnology.

92. David C. Campbell – Director of Eppendorf, advancing biotechnology in laboratory automation.

93. Richard P. Lifton – Chair of Genetics at Yale University, pioneering work in genomic medicine and biotechnology.

94. Rosalind Franklin – Researcher in molecular biology, advancing biotechnology in DNA sequencing.

95. Edward D. Williams – CEO of NantKwest, specializing in immuno-oncology biotechnology solutions.

96. David M. Hartman – Chief Technology Officer at EnGen Biotech, pushing boundaries in gene editing technologies.

97. Margaret Hamburg – Former FDA Commissioner, influencing biotechnology policy and regulation.

98. John C. Martin – Former CEO of Gilead Sciences, advancing biotech research in HIV/AIDS.

99. Paul Wiggins – Co-founder of Horizon Discovery, advancing gene editing biotechnology.

100. Chad K. Voss – Chief Operating Officer at Bluebird Bio, leading biotech efforts in gene therapy and rare diseases.

The world’s Top 100 biotechnology speakers and thought leaders continue to drive innovation in the sector, helping with advancing treatments, improving patient outcomes, and pushing the boundaries of scientific discovery.